Hua Medicine (Shanghai) Ltd. Share Price OTC Markets
Equities
HUMDF
KYG4644K1022
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2028 USD | -54.93% | -.--% | -.--% |
03-28 | Hua Medicine Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Hua Medicine Ltd. Appoints Yi Zhang as Executive Director with Effect from January 1, 2024 | CI |
Sales 2022 | 17.6M 2.43M 191M | Sales 2023 | 76.61M 10.58M 830M | Capitalization | 1.75B 242M 18.99B |
---|---|---|---|---|---|
Net income 2022 | -204M -28.17M -2.21B | Net income 2023 | -211M -29.14M -2.29B | EV / Sales 2022 | 159 x |
Net cash position 2022 | 393M 54.28M 4.26B | Net cash position 2023 | 1.29B 179M 14.02B | EV / Sales 2023 | 6 x |
P/E ratio 2022 |
-15.7
x | P/E ratio 2023 |
-8.28
x | Employees | 177 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 86.36% |
Latest transcript on Hua Medicine (Shanghai) Ltd.
1 day | -54.93% |
Managers | Title | Age | Since |
---|---|---|---|
Li Chen
FOU | Founder | 61 | 09/11/09 |
Li Changhong
CTO | Chief Tech/Sci/R&D Officer | 55 | - |
Di Hong
COO | Chief Operating Officer | 45 | 30/04/21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Nelsen
CHM | Chairman | 60 | 22/04/10 |
William Keller
BRD | Director/Board Member | 75 | - |
Yiu Wa Tsui
BRD | Director/Board Member | 74 | 31/08/18 |
1st Jan change | Capi. | |
---|---|---|
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B | |
+77.64% | 8.87B |
- Stock Market
- Equities
- 2552 Stock
- HUMDF Stock